Characterization of the pharmacodynamic activity of AGEN1181, an Fc-enhanced CTLA-4 antibody, alone and in combination with the PD-1 antibody balstilimab.-MedSci.cn

Characterization of the pharmacodynamic activity of AGEN1181, an Fc-enhanced CTLA-4 antibody, alone and in combination with the PD-1 antibody balstilimab.

Shapiro, I; Lim, M; Pabla, S; O'Day, SJ; El-Khoueiry, A; Ramamurthy, C; Bullock, AJ; Gordon, MS; Buell, J; Chand, D; Wijatyk, A

CANCER RESEARCH, 2021; 81 (13):

科室
- - 订阅+
  - 更多科室
工具
服务